Endig, Loreto V.
HRN: 14-43-28 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2023
CEFTRIAXONE 1G (VIAL)
07/18/2023
07/24/2023
IV
2g
Q24
UTI
Waiting Final Action